Greater arterial stiffness in polycystic ovary syndrome (PCOS) is an obesity- but not a PCOS-associated phenomenon

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 10, 2010, Pages 4566-4575

  Ketel, Iris J G ^a   Stehouwer, C D ^a   Henry, R M ^a   Serne E H ^b   Hompes, P ^a   Homburg, R ^a   Smulders, Y M ^b   Lambalk, C B ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTERIAL STIFFNESS; ARTERIAL WALL THICKNESS; ARTERY COMPLIANCE; ARTICLE; AUGMENTATION INDEX; BRACHIAL ARTERY; CARDIOVASCULAR RISK; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ECHOGRAPHY; FEMALE; FEMORAL ARTERY; GROUPS BY AGE; HUMAN; MEAN ARTERIAL PRESSURE; OBESITY; OVARY POLYCYSTIC DISEASE; PRIORITY JOURNAL; PULSE WAVE; WAIST CIRCUMFERENCE; YOUNG MODULUS;

EID: 77957819280     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2010-0868     Document Type: Article

References (44)

1. Franks S 1995 Polycystic ovary syndrome. N Engl J Med 333:853-861
2. Legro RS 2003 Polycystic ovary syndrome and cardiovascular disease: a premature association? Endocr Rev 24:302-312
3. Shaw LJ, Bairey Merz CN, Azziz R, Stanczyk FZ, Sopko G, Braunstein GD, Kelsey SF, Kip KE, Cooper-Dehoff RM, Johnson BD, Vaccarino V, Reis SE, Bittner V, Hodgson TK, Rogers W, Pepine CJ 2008 Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health National - Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. J Clin Endocrinol Metab 93:1276-1284
4. Gambineri A, Pelusi C, Vicennati V, Pagotto U, Pasquali R 2002 Obesity and the polycystic ovary syndrome. Int J Obes Relat Metab Disord 26:883-896
5. De Michele M, Panico S, Iannuzzi A, Celentano E, Ciardullo AV, Galasso R, Sacchetti L, Zarrilli F, Bond MG, Rubba P 2002 Association of obesity and central fat distribution with carotid artery wall thickening in middle-aged women. Stroke 33:2923-2928
6. Ferreira I, Snijder MB, Twisk JW, van Mechelen W, Kemper HC, Seidell JC, Stehouwer CD 2004 Central fat mass versus peripheral fat and lean mass: opposite (adverse versus favorable) associations with arterial stiffness? The Amsterdam Growth and Health Longitudinal Study. J Clin Endocrinol Metab 89:2632-2639
7. Misra A, Vikram NK 2003 Clinical and pathophysiological consequences of abdominal adiposity and abdominal adipose tissue depots. Nutrition 19:457-466
8. Vrbikova J, Hainer V 2009 Obesity and polycystic ovary syndrome. Obes Facts 2:26-35
9. Ketel IJ, Stehouwer CD, Serné EH, Korsen TJ, Hompes PG, Smulders YM, de Jongh RT, Homburg R, Lambalk CB 2008 Obese but not normal-weight women with polycystic ovary syndrome are characterized by metabolic and microvascular insulin resistance. J Clin Endocrinol Metab 93:3365-3372
10. Diamanti-Kandarakis E, Papavassiliou AG, Kandarakis SA, Chrousos GP 2007 Pathophysiology and types of dyslipidemia in PCOS. Trends Endocrinol Metab 18:280-285
11. Cibula D, Cífková R, Fanta M, Poledne R, Zivny J, Skibová J 2000 Increased risk of non-insulin dependent diabetes mellitus, arterial hypertension and coronary artery disease in perimenopausal women with a history of the polycystic ovary syndrome. Hum Reprod 15:785-789
12. Kelly CJ, Speirs A, Gould GW, Petrie JR, Lyall H, Connell JM 2002 Altered vascular function in young women with polycystic ovary syndrome. J Clin Endocrinol Metab 87:742-746
13. Lakhani K, Seifalian AM, Hardiman P 2002 Impaired carotid viscoelastic properties in women with polycystic ovaries. Circulation 106:81-85
14. Meyer C, McGrath BP, Teede HJ 2005 Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease. J Clin Endocrinol Metab 90:5711-5716
15. Muneyyirci-Delale O, Winer N, Oklander V, Joulak I, Dalloul N, Nacharaju V, Dham S, von Gizycki H 2007 Vascular compliance in women with polycystic ovary syndrome and healthy women. J Cardiometab Syndr 2:40-44
16. Soares GM, Vieira CS, Martins WP, Franceschini SA, Dos Reis RM, Silva de Sá MF, Ferriani RA 2008 Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome? Clin Endocrinol (Oxf) 71:406-411
17. Trakakis E, Balanika A, Baltas C, Loghis C, Simeonidis G, Vaggopoulos V, Papakonstantinou O, Gouliamos A, Salamalekis G, Kassanos D 2008 Hemodynamic alterations and wall properties in large arteries of young, normotensive, and non-obese women with polycystic ovary syndrome. J Endocrinol Invest 31:1001-1007
18. Gatzka CD, Cameron JD, Kingwell BA, Dart AM 1998 Relation between coronary artery disease, aortic stiffness, and left ventricular structure in a population sample. Hypertension 32:575-578
19. Giannattasio C, Failla M, Stella ML, Mangoni AA, Carugo S, Pozzi M, Grassi G, Mancia G 1995 Alterations of radial artery compliance in patients with congestive heart failure. Am J Cardiol 76:381-385
20. Hirai T, Sasayama S, Kawasaki T, Yagi S 1989 Stiffness of systemic arteries in patients with myocardial infarction. A noninvasive method to predict severity of coronary atherosclerosis. Circulation 80:78-86
21. Westerhof N, O'Rourke MF 1995 Haemodynamic basis for the development of left ventricular failure in systolic hypertension and for its logical therapy. J Hypertens 13:943-952
22. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group 2004 Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19:41-47
23. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus 2003 Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 26(Suppl 1):S5-S20
24. de Boer JA, Lambalk CB, Hendriks HH, van Aken C, van der Veen EA, Schoemaker J 2004 Growth hormone secretion is impaired but not related to insulin sensitivity in non-obese patients with polycystic ovary syndrome. Hum Reprod 19:504-509
25. van Hooff MH, van der Meer M, Lambalk CB, Schoemaker J 1999 Variation of luteinizing hormone and androgens in oligomenorrhoea and its implications for the study of polycystic ovary syndrome. Hum Reprod 14:1684-1689
26. Brands PJ, Hoeks AP, Willigers J, Willekes C, Reneman RS 1999 An integrated system for the non-invasive assessment of vessel wall and hemodynamic properties of large arteries by means of ultrasound. Eur J Ultrasound 9:257-266
27. Ferreira I, Twisk JW, Van Mechelen W, Kemper HC, Stehouwer CD 2002 Current and adolescent levels of cardiopulmonary fitness are related to large artery properties at age 36: the Amsterdam Growth and Health Longitudinal Study. Eur J Clin Invest 32:723-731
28. Henry RM, Kostense PJ, Spijkerman AM, Dekker JM, Nijpels G, Heine RJ, Kamp O, Westerhof N, Bouter LM, Stehouwer CD 2003 Arterial stiffness increases with deteriorating glucose tolerance status: the Hoorn Study. Circulation 107:2089-2095
29. Schram MT, Henry RM, van Dijk RA, Kostense PJ, Dekker JM, Nijpels G, Heine RJ, Bouter LM, Westerhof N, Stehouwer CD 2004 Increased central artery stiffness in impaired glucose metabolism and type 2 diabetes: the Hoorn Study. Hypertension 43:176-181 (Pubitemid 38174170)
30. Van Bortel LM, Duprez D, Starmans-Kool MJ, Safar ME, Giannattasio C, Cockcroft J, Kaiser DR, Thuillez C 2002 Clinical applications of arterial stiffness, Task Force III: recommendations for user procedures. Am J Hypertens 15:445-452
31. Serné EH, Stehouwer CD, ter Maaten JC, ter Wee PM, Rauwerda JA, Donker AJ, Gans RO 1999 Microvascular function relates to insulin sensitivity and blood pressure in normal subjects. Circulation 99:896-902
32. Serné EH, Gans RO, ter Maaten JC, ter Wee PM, Donker AJ, Stehouwer CD 2001 Capillary recruitment is impaired in essential hypertension and relates to insulin's metabolic and vascular actions. Cardiovasc Res 49:161-168
33. Ferrannini E, Mari A 1998 How to measure insulin sensitivity. J Hypertens 16:895-906
34. Snijder MB, Henry RM, Visser M, Dekker JM, Seidell JC, Ferreira I, Bouter LM, Yudkin JS, Westerhof N, Stehouwer CD 2004 Regional body composition as a determinant of arterial stiffness in the elderly: the Hoorn Study. J Hypertens 22:2339-2347
35. Dokras A 2008 Cardiovascular disease risk factors in polycystic ovary syndrome. Semin Reprod Med 26:39-44
36. Wild RA 2002 Long-term health consequences of PCOS. Hum Reprod Update 8:231-241
37. Talbott EO, Guzick DS, Sutton-Tyrrell K, McHugh-Pemu KP, Zborowski JV, Remsberg KE, Kuller LH 2000 Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 20:2414-2421
38. Dahlgren E, Janson PO, Johansson S, Lapidus L, Odén A 1992 Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women. Acta Obstet Gynecol Scand 71:599-604
39. Pierpoint T, McKeigue PM, Isaacs AJ, Wild SH, Jacobs HS 1998 Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 51:581-586
40. Wild S, Pierpoint T, Jacobs H, McKeigue P 2000 Long-term consequences of polycystic ovary syndrome: results of a 31 year follow-up study. Hum Fertil (Camb) 3:101-105
41. Birdsall MA, Farquhar CM, White HD 1997 Association between polycystic ovaries and extent of coronary artery disease in women having cardiac catheterization. Ann Intern Med 126:32-35
42. Dahlgren E, Johansson S, Lindstedt G, Knutsson F, Odén A, Janson PO, Mattson LA, Crona N, Lundberg PA 1992 Women with polycystic ovary syndrome wedge resected in 1956 to 1965: a long-term follow-up focusing on natural history and circulating hormones. Fertil Steril 57:505-513
43. Wild S, Pierpoint T, McKeigue P, Jacobs H 2000 Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study. Clin Endocrinol (Oxf) 52:595-600
44. Eckel RH, Barouch WW, Ershow AG 2002 Report of the National Heart, Lung, and Blood Institute - National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the Pathophysiology of Obesity-Associated Cardiovascular Disease. Circulation 105:2923-2928